Home › Diffuse Large B-Cell Lymphoma › Virginia › Richmond

Pag-aaral pangklinika para sa Diffuse Large B-Cell Lymphoma sa Richmond, VA

Isang pag-aaral para sa Diffuse Large B-Cell Lymphoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Richmond. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma

Nagre-recruitPhase 2

VCU Massey Comprehensive Cancer Center, Richmond

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06649812

A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies

Nagre-recruitPhase 1/2

Virginia Commonwealth University Massey Cancer Center, Richmond

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT05006716

A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)

Nagre-recruitPhase 3

Virginia Cancer Institute ( Site 0148), Richmond

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06717347

A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)

Nagre-recruitPhase 2

VCU Health Adult Outpatient Pavillion ( Site 0138), Richmond

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06890884

A Study of ARC-02 in B-cell NHL

Nagre-recruitPhase 1

Massey Cancer Center, Richmond

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 26, 2026 · NCT07691606

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

Nagre-recruitPhase 1/2

Virginia Commonwealth University-Massey Cancer Center, Richmond

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT05826535

Epcoritamab Plus Ibrutinib for the Treatment of Relapsed or Refractory Aggressive B-Cell Non-Hodgkin Lymphoma

Nagre-recruitPhase 1/2

VCU Massey Comprehensive Cancer Center, Richmond

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT06536049

Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

Nagre-recruitPhase 2

VCU Massey Comprehensive Cancer Center, Richmond

Edad 18 pataas · Lahat ng kasarian · Na-update Peb 2, 2026 · NCT05633615

Zanubrutinib in Patients With DLBCL and MYD88 or NOTCH1 Mutation or CD5+

Nagre-recruitPhase 2

Virginia Commonwealth University, Richmond

Edad 18 pataas · Lahat ng kasarian · Na-update Ene 23, 2026 · NCT06846463

Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment

Nagre-recruitPhase 2

VCU Massey Cancer Center at Stony Point, Richmond
VCU Massey Comprehensive Cancer Center, Richmond

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 20, 2025 · NCT05890352

Pag-aaral para sa Diffuse Large B-Cell Lymphoma sa ibang lungsod

Iba pang pag-aaral sa Richmond

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.